History of hypertension was reported more frequently in the patients with IPA (seven of nine vs six of 18, p=0·046). No other significant differences were observed in terms of age, EORTC-MSG risk factors for IPA, time between onset of symptoms and intubation and time between onset of symptoms or intubation and Aspergillus spp respiratory specimen collection, severity, laboratory data, non-COVID CT-scan images, and steroid administration. Antifungal therapy was initiated in two of nine (22%) patients with IPA. Mortality rate did not differ between IPA and non-IPA patients (four of nine [44%] vs seven of 18 [39%], p=0·99.